Feedback / Questions
isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci
https://www.businesswire.com/news/home/20230228005186/en/MyMD-Pharmaceuticals%C2%AE-Announces-Upcoming-Presentation-of-Preclinical-Rheumatoid-Arthritis-Data-for-Oral-TNF-%CE%B1-Inhibitor-MYMD-1%C2%AE-at-the-Society-of-Toxicology-2023-Annual-Meeting
Feb 28, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next